Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 9.259B	--
--	2024/FY	-- / 8.187B	--
Mar 22, 2024	2023/FY	7.703B / 8.380B	--
Mar 23, 2023	2022/FY	8.282B / 8.537B	--
Mar 19, 2022	2021/FY	8.254B / 9.065B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 9.259B--

--2024/FY-- / 8.187B--

Mar 22, 20242023/FY7.703B / 8.380B--

Mar 23, 20232022/FY8.282B / 8.537B--

Mar 19, 20222021/FY8.254B / 9.065B--

Unlock Free Earnings Estimates

Open Account

KPC Pharmaceuticals, Inc. Earnings Reports

KPC Group Report for the Third Quarter of 2024

Oct 25 12:00 ET

kpc pharmaceuticals, inc. Semi-Annual Report for 2024

Aug 22 12:00 ET

Summary of kpc pharmaceuticals, inc.'s 2024 interim report

Aug 22 12:00 ET

KPC Group Report for the First Quarter of 2024

Apr 19 12:00 ET

Symbol Price % Chg

Zhejiang Zoenn Design

300901

14.86 +20.03%

Zhejiang Meorient Commerce & Exhibition Inc.

300795

22.36 +20.02%

Fujian Zitian Media Technology

300280

22.18 +20.02%

Zhejiang Prulde Electric Appliance

301353

36.46 +20.01%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 14, 2024

Strong Buy

Strong Buy
82.61%
Buy
17.39%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

State-owned Enterprise Reform

Intraday-1.75%